Literature DB >> 15720214

Adult stem cell application in spinal cord injury.

Sherri S Schultz1.   

Abstract

The mechanical force incurred by spinal cord injury results in degenerative neural tissue damage beyond the site of initial injury. By nature, the central nervous system (CNS) does not regenerate itself. Cell therapy, in particular, stem cell implantation has become a possible solution for spinal cord injury. Embryonic stem cells and fetal stem cells are the forefathers of the field of stem cell therapy. Isolation and preparation of specific populations of adult stem cells have evolved to the point of stable, long-term culturing with the capability to differentiate into neural phenotypes from all three of the neural lineages: neurons, astrocytes, and oligodendrocytes. Thus, adult stem cells will transcend ethical concerns, technical difficulties, and probably immunorejection. A variety of adult stem cells have been implanted in a rat model of spinal cord injury, ranging from olfactory ensheathing cells, cultured spinal cord stem cells, bone marrow derived stem cells, dermis derived stem cells, and a few others. Although no definite decisions on which adult stem cells are most effective for this CNS injury, their ability to incorporate into the spinal cord, differentiate, and to improve locomotor recovery hold promise for a cure.

Entities:  

Mesh:

Year:  2005        PMID: 15720214     DOI: 10.2174/1389450053345046

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  14 in total

1.  Human Neural Stem Cells with GDNF Site-Specific Integration at AAVS1 by Using AAV Vectors Retained Their Stemness.

Authors:  Jinju Zhang; Xiaomei Liu; Yun Zhang; Zuo Luan; Yinxiang Yang; Zhaoyan Wang; Chun Zhang
Journal:  Neurochem Res       Date:  2018-02-12       Impact factor: 3.996

2.  Development of a model of sacrocaudal spinal cord injury in cloned Yucatan minipigs for cellular transplantation research.

Authors:  Ji-Hey Lim; Jorge A Piedrahita; Lauren Jackson; Troy Ghashghaei; Natasha J Olby
Journal:  Cell Reprogram       Date:  2010-12       Impact factor: 1.987

Review 3.  Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain.

Authors:  Ken P Ehrhardt; Susan M Mothersele; Andrew J Brunk; Jeremy B Green; Mark R Jones; Craig B Billeaud; Alan David Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

4.  Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs.

Authors:  Ji Hey Lim; Ye Eun Byeon; Hak Hyun Ryu; Yun Hyeok Jeong; Young Won Lee; Wan Hee Kim; Kyung Sun Kang; Oh Kyeong Kweon
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

5.  Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair.

Authors:  Kuan-Min Fang; Jen-Kun Chen; Shih-Chieh Hung; Mei-Chun Chen; Yi-Ting Wu; Tsung-Jung Wu; Hsin-I Lin; Chia-Hua Chen; Henrich Cheng; Chung-Shi Yang; Shun-Fen Tzeng
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats.

Authors:  Hui Yao; Mou Gao; Jianhua Ma; Maoying Zhang; Shaowu Li; Bingshan Wu; Xiaohu Nie; Jiao Jiao; Hao Zhao; Shanshan Wang; Yuanyuan Yang; Yesen Zhang; Yilin Sun; Max S Wicha; Alfred E Chang; Shaorong Gao; Qiao Li; Ruxiang Xu
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

7.  Impact of fetal brain tissue derived mesenchymal stem cell and fibrin glue on facial nerve crash injury

Authors:  Ömer Bayır; Tuğba Karagöz; Ferda Alpaslan Pınarlı; Gülistan Sanem Sarıbaş; Candan Özoğul; Kemal Keseroğlu; Güleser Saylam; Emel Çadallı Tatar; Sevilay Karahan; Bülent Öcal; Mehmet Hakan Korkmaz
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

8.  Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions.

Authors:  Renaud Quertainmont; Dorothée Cantinieaux; Olivier Botman; Selim Sid; Jean Schoenen; Rachelle Franzen
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

9.  Stem cell therapy for neuropathic pain treatment.

Authors:  D Siniscalco; F Rossi; S Maione
Journal:  J Stem Cells Regen Med       Date:  2007-11-14

10.  Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury.

Authors:  Bingzhou Cui; En Li; Bo Yang; Bo Wang
Journal:  Exp Ther Med       Date:  2014-03-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.